|
Name |
3β,20-dihydroxy-protosta-16,24-dien-29-oic acid
|
| Molecular Formula | C30H48O4 | |
| IUPAC Name* |
3-hydroxy-17-(2-hydroxy-6-methylhept-5-en-2-yl)-4,8,10,14-tetramethyl-2,3,5,6,7,9,11,12,13,15-decahydro-1H-cyclopenta[a]phenanthrene-4-carboxylicacid
|
|
| SMILES |
CC(C)=CCCC(C)(O)C1=CCC2(C)C1CCC1C3(C)CCC(O)C(C)(C(=O)O)C3CCC12C
|
|
| InChI |
InChI=1S/C30H48O4/c1-19(2)9-8-15-29(6,34)21-12-17-27(4)20(21)10-11-22-26(3)16-14-24(31)30(7,25(32)33)23(26)13-18-28(22,27)5/h9,12,20,22-24,31,34H,8,10-11,13-18H2,1-7H3,(H,32,33)/t20-,22-,23+,24-,26+,27-,28-,29?,30+/m0/s1
|
|
| InChIKey |
VLDXQMCAKXKUGY-ZSFARPFBSA-N
|
|
| Synonyms |
NA
|
|
| CAS | NA | |
| PubChem CID | NA | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 472.71 | ALogp: | 6.5 |
| HBD: | 3 | HBA: | 3 |
| Rotatable Bonds: | 5 | Lipinski's rule of five: | Rejected |
| Polar Surface Area: | 77.8 | Aromatic Rings: | 4 |
| Heavy Atoms: | 34 | QED Weighted: | 0.401 |
| Caco-2 Permeability: | -5.228 | MDCK Permeability: | 0.00001570 |
| Pgp-inhibitor: | 0.003 | Pgp-substrate: | 0 |
| Human Intestinal Absorption (HIA): | 0.074 | 20% Bioavailability (F20%): | 0.675 |
| 30% Bioavailability (F30%): | 0.098 |
| Blood-Brain-Barrier Penetration (BBB): | 0.968 | Plasma Protein Binding (PPB): | 98.37% |
| Volume Distribution (VD): | 0.821 | Fu: | 3.24% |
| CYP1A2-inhibitor: | 0.007 | CYP1A2-substrate: | 0.269 |
| CYP2C19-inhibitor: | 0.011 | CYP2C19-substrate: | 0.903 |
| CYP2C9-inhibitor: | 0.074 | CYP2C9-substrate: | 0.362 |
| CYP2D6-inhibitor: | 0.005 | CYP2D6-substrate: | 0.11 |
| CYP3A4-inhibitor: | 0.145 | CYP3A4-substrate: | 0.179 |
| Clearance (CL): | 5.932 | Half-life (T1/2): | 0.024 |
| hERG Blockers: | 0.005 | Human Hepatotoxicity (H-HT): | 0.204 |
| Drug-inuced Liver Injury (DILI): | 0.01 | AMES Toxicity: | 0.01 |
| Rat Oral Acute Toxicity: | 0.198 | Maximum Recommended Daily Dose: | 0.578 |
| Skin Sensitization: | 0.042 | Carcinogencity: | 0.195 |
| Eye Corrosion: | 0.003 | Eye Irritation: | 0.031 |
| Respiratory Toxicity: | 0.942 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC005284 | ![]() |
0.471 | D0X7XG | ![]() |
0.387 | ||
| ENC002152 | ![]() |
0.460 | D0B4RU | ![]() |
0.292 | ||
| ENC000865 | ![]() |
0.412 | D03MTN | ![]() |
0.281 | ||
| ENC005283 | ![]() |
0.400 | D0Q6NZ | ![]() |
0.276 | ||
| ENC001478 | ![]() |
0.387 | D03ZTE | ![]() |
0.273 | ||
| ENC001833 | ![]() |
0.376 | D0G3SH | ![]() |
0.273 | ||
| ENC002246 | ![]() |
0.370 | D0M4WA | ![]() |
0.272 | ||
| ENC001918 | ![]() |
0.361 | D0W5LS | ![]() |
0.272 | ||
| ENC001582 | ![]() |
0.357 | D0U3GL | ![]() |
0.267 | ||
| ENC002119 | ![]() |
0.346 | D0I2SD | ![]() |
0.262 | ||